Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. - Wikidata - wikimedia - TriplyDB

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.

http://www.wikidata.org/entity/Q35037783

about

A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges Potential of epigenetic therapies in the management of solid tumors Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients Genetic disorders coupled to ROS deficiency The Vegetative State and Stem Cells: Therapeutic Considerations Bioprinting and Differentiation of Stem Cells Describing the Stem Cell Potency: The Various Methods of Functional Assessment and In silico Diagnostics Characterization of a Murine Model of Bioequivalent Bladder Wound Healing and Repair Following Subtotal Cystectomy Diverging Concepts and Novel Perspectives in Regenerative Medicine.Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells Chemical genetics and regeneration.Applications of stem cell biology to oculoplastic surgery.Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Induced pluripotent stem cells as a cellular model for studying Down Syndrome.Effect of aging on stem cells.Mesenchymal stem cells for therapeutic applications in pulmonary medicine.Stem cells - biological update and cell therapy progress.Induced Pluripotent Stem Cell-Derived Endothelial Cells in Insulin Resistance and Metabolic Syndrome.Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease.Human dermal fibroblasts in psychiatry research.Krüppel-like factors in mammalian stem cells and development.The state of the art of islet transplantation and cell therapy in type 1 diabetes.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.10th anniversary of iPS cells: the challenges that lie ahead.Use of genome-editing tools to treat sickle cell disease.Full biological characterization of human pluripotent stem cells will open the door to translational research.Current status in cancer cell reprogramming and its clinical implications.Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology.Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes Using stem cell biology to study and treat ophthalmologic and oculoplastic diseases miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming OCT4 impedes cell fate redirection by the melanocyte lineage master regulator MITF in mouse ESCs

P2860

Q26741371-B05F5F47-8ADF-40FA-A1CE-5025808CC6E8 Q26747501-7CCBEB57-9175-4D04-AD03-5B476340EBA0 Q26771698-4C4EAE6F-FCF7-43CC-928C-2EBD4218364F Q26772309-AFB79DA9-C9E4-4F31-852D-8E21E78654B5 Q26775061-55673E9B-0E07-41DD-BD6B-6CDDA27A9F20 Q26783134-10D11BF4-FDA7-4BA4-A5D3-799C5199FEB9 Q26784399-C64FF241-F45D-4262-AD9A-5CB5EA3CC656 Q26799545-A19F4CC0-1FA8-4FC8-B924-680E6EFAB965 Q28066108-F912CD5C-C4E4-4174-9C96-3102F384F250 Q28076630-21DB80D9-103F-4ABA-A580-6F48CDC0B614 Q28080291-797401BD-BDA5-4664-976F-5450EA73178B Q30252307-77C66316-2C04-4AC0-A4A2-E51BDF664A2D Q33755185-D10CE34C-9AFD-48F0-A282-6C356B04D169 Q35747887-75FB63B2-F54A-4920-8B88-9F4567A93B02 Q35825358-8D965805-6F1F-4D5F-9A36-D5DD17BFC4B6 Q36024221-5894FBE0-3EE7-4612-BEC4-40D15723C6D2 Q36904682-452170E2-BB74-44ED-9032-FF4536179764 Q37581014-5014A5DB-FC4E-4CFC-B0DE-38770FF98A64 Q37652063-650A7BF1-C5F3-4117-9D32-D0C5C86193A0 Q38524367-57CEC6DF-29D6-414F-98DE-0BD6F574BA99 Q38648343-3614B29A-1C27-4392-807A-0AA06EA6062F Q38669207-B0FB0C86-EA60-4117-9A5A-262217FC3693 Q38695115-EF21B72E-1664-4D6C-A36E-15D7B421FE89 Q38726048-190BE957-8691-49B0-A3AF-AD41DD1F5522 Q38752257-A18384B6-4E36-43F7-ACEA-46B367E8E1D2 Q38753743-492B619F-97FA-4520-8668-4C49026C8842 Q38767261-DECB8095-AA40-4864-A5D0-D33D53AC5CAB Q38816786-0C49F4BF-541A-42D6-AFE4-495C8E1A4A04 Q38844338-7B5CF1E0-4727-4C5F-A632-B217B65406CE Q38850483-B8202557-CDA7-478E-9825-62D6623268DC Q38871443-2706EDF8-B56F-41B7-B04F-688B6A4E2CB3 Q38952695-072FD5E6-FBA8-4E78-8306-83E1CC87D4DB Q39024182-5E7287B6-5080-4269-AA2C-849465DE1ADB Q39126523-A19D32DB-9EF3-4817-A974-82F99168DD37 Q39265792-3CC5DD10-1726-4D67-9B75-5232350895E8 Q41718616-81D6013D-CCAE-4F5C-A5DC-44760BC0150A Q41927296-354F7B91-AAF2-4FB2-8A32-1498F744FAF3 Q42359954-476AE6FE-1BC4-40FA-8924-974D3EF3783B Q42368111-413F3B5D-8088-4A43-82E6-E47D14C29E95 Q42380162-98A6E335-A6E2-4EF3-B6B4-A67A0C2239CE

P2860

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.

http://www.wikidata.org/entity/Q35037783

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Induced pluripotent stem cells ...... modeling, and drug discovery.

@ast

Induced pluripotent stem cells ...... modeling, and drug discovery.

@en

type

label

Induced pluripotent stem cells ...... modeling, and drug discovery.

@ast

Induced pluripotent stem cells ...... modeling, and drug discovery.

@en

prefLabel

Induced pluripotent stem cells ...... modeling, and drug discovery.

@ast

Induced pluripotent stem cells ...... modeling, and drug discovery.

@en

P1433

Q35037783-DEC18A2E-BCD0-410F-87AA-715E73608524

P1476

Q35037783-298F611C-D81B-4B39-910A-1378BD307212

P2093

Q35037783-631B51A8-E7A9-4734-96F6-D2D74A0D1D42

Q35037783-6B11EB58-E292-47FF-9A70-B48A493CC138

Q35037783-C768820E-6393-4977-8A01-A931E9AF5957

Q35037783-C84CBDC1-59FF-4D40-95A7-66A78577D7ED

Q35037783-EED3316D-0D64-4834-8545-FEDD99707BC2

P2860

Q35037783-04275045-9EB9-4F67-9634-64FACACC7488

Q35037783-045DA887-2C67-458E-90F4-5702C706B9E1

Q35037783-06961B14-21E3-4B9D-B65F-3E82B410822D

Q35037783-072ABA8E-95C8-4925-B9D4-F8C75441C4AD

Q35037783-0BA9CD13-8A35-4527-BC84-7B0C8C10A928

Q35037783-0F47FCCB-1DDA-46B7-A0A6-B104C07D4A8A

Q35037783-164CF962-5441-462F-A7FE-385D028A708E

Q35037783-168A0CFD-6E37-4DF9-A48D-E81E0E93F2AF

Q35037783-17DAD4E1-6749-42F7-9251-970B388B7AFF

Q35037783-18867838-ED2A-41E9-8ACD-D7E5BA03E2FB

P304

Q35037783-3B11CB33-15F8-433F-8324-45C6D4A46419

P31

Q35037783-E9F0771F-D6D7-4791-88E8-BAF2292AAB68

P356

Q35037783-ED302EEE-BFF8-42F2-8934-1C09A4919DE0

P478

Q35037783-614057B3-6F01-4032-8B91-6BBDDCAD8673

P577

Q35037783-2ECC76F2-CDAB-49C6-B42D-A00F2C584F6F

P5875

Q35037783-7088E5DD-75BA-463C-8920-8BB14AE7C284

P698

Q35037783-170ABE97-9A9A-4174-9537-EC3E05EF1BFA

P932

Q35037783-FAF92FE5-E52E-47B6-8412-F822B5E89817

P356

FCELL.2015.00002

P1433

Frontiers in cell and developmental biology

P1476

Induced pluripotent stem cells ...... modeling, and drug discovery.

@en

P2093

Abhishek Saini

http://www.w3.org/2001/XMLSchema#string

Manisha Kalsan

http://www.w3.org/2001/XMLSchema#string

Neeraj Kumar

http://www.w3.org/2001/XMLSchema#string

Ramesh Chandra

http://www.w3.org/2001/XMLSchema#string

Vimal K Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions

A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells

Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation

Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells

Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells

Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice

Disease-specific induced pluripotent stem cells

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCELL.2015.00002

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272407027

http://www.w3.org/2001/XMLSchema#string

P698

25699255

http://www.w3.org/2001/XMLSchema#string

P932

4313779

http://www.w3.org/2001/XMLSchema#string